Skip to main content

BlackRock Inc.

Position in MRNA — Moderna, Inc.

CIK 1364742 New York, NY

Position in MRNA

as of Jun 30, 2024 · filed Aug 13, 2024
Position Value
$3,035,525,609
+$329,340,862 QoQ
Shares Held
25,562,321
+0.7% QoQ
Ownership
6.40%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 91% Shared 0% None 9%

Common Shares in MRNA Over Time

Shares Held

Position Value (USD)

Derivatives in MRNA

reported options exposure · as of Sep 30, 2021
CallValue
$2,694,020
CallShares
7,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2024

BlackRock Inc. holds $54,091,702,062 across 441 Biotechnology names. MRNA ranks #3 (5.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 MRNA
Moderna, Inc.
This page
25,562,321 $3,035,525,609

All Filings in MRNA

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2024-06-30 $3,035,525,609 25,562,321
2024-03-31 $2,706,184,747 25,395,878
2023-12-31 $2,516,253,258 25,301,692
2023-09-30 $2,555,331,171 24,739,386
2023-06-30 $2,935,890,883 24,163,711
2023-03-31 $3,853,807,195 25,093,158
2022-12-31 $4,690,920,523 26,115,803
2022-09-30 $3,003,804,350 25,402,151
2022-06-30 $3,745,153,007 26,217,382
2022-03-31 $4,939,027,509 28,671,935
2021-12-31 $7,025,460,902 27,661,473
2021-09-30 $10,345,868,085 26,882,160
2021-09-30 $2,694,020 7,000
2021-06-30 $4,556,432,550 19,390,725
2021-03-31 $2,724,204,828 20,803,397
2020-12-31 $2,139,202,303 20,476,714
2020-09-30 $1,431,751,117 20,236,765
2020-06-30 $1,272,908,597 19,824,149
2020-03-31 $370,581,467 12,373,338